Multi-locus approach in pharmacogenetics. Application in the cholesterol lowering and anti-inflammatory pathways of statins

Completed

• Conditions: Myocardial infarction; 10028593; 10003216

• Registration Number: NL-OMON29788
• Lead Sponsor: Zorgonderzoek Nederland (ZON)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 12 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 2400

Inclusion Criteria

age > 18 years
Hypercholesterolemia: defined as total cholesterol levels >5 mmol/l or use of cholesterol lowering medication

Exclusion Criteria

controls: Myocardial infarction in medical history

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>We will use different statistical methods to study the interaction between<br /><br>statin use, SNPs, and MI.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>na</p><br>